Search Site
Cancer Genetics

ONCOSEQ DNALAB FUSION PANEL

ONCOSEQ DNALAB FUSION PANEL

(26 RNA GENES – 75 FUSION GENES)

Gene fusions occurring in cancer cells; It is clinically very important in evaluating the prognosis regarding diagnosis, treatment and drug use of the disease. It also allows us to determine which mutation causes uncontrolled division in which signaling pathways in cancer. Studies have identified gene-specific rearrangements that result in fusion (chimeric) gene formation in many different tumor groups.

  • ALK
  • BRAF
  • BRD4
  • EGFR
  • ERG
  • ETV1
  • ETV4
  • ETV6
  • EWSR1
  • FGFR1
  • FGFR2
  • FGFR3
  • MET
  • MYB
  • NOTCH2
  • NRGl
  • NTRK1
  • NTRK2
  • NTRK3
  • TNlJTMl
  • PDGFRA
  • PDGFRB
  • RET
  • ROS1
  • TERT
  • TFE

  • Test:
    Fusion Test
  • Method:
    Next Generation Sequencing
  • Analysis Time:
    14-21 Days
  • Sample Type:
    FFPE (Tissue) or cfDNA
  • Storage Conditions:
    1 week at +4 C
  • Transport Conditions:
    The same day; At room temperature
  • Rejection Criteria:
    Hemolyzed, Lipemic, Icteric samples are not accepted

Discover Your Genetic Heritage

You can contact us to get information about our genetic tests, consultancy services and more.

Contact Us

ONCOSEQ DNALAB (Cancer Genetics)

PRIMIS Non-Invasive Prenatal Test

Preimplantation Genetic Diagnosis (PGD)

Tüm Ekzom Dizileme

Clinical Exome Sequencing

Rare Diseases

Carrier Panels - SMARİS